PureTech Health is a biotechnology company which develops medicines to combat serious diseases.
Company profile
Ticker
PRTC, PTCHF
Exchange
Website
CEO
Daphne Zohar
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
PRTC stock data
Latest filings (excl ownership)
20-F
2023 FY
Annual report (foreign)
25 Apr 24
6-K
Current report (foreign)
25 Apr 24
6-K
PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions
9 Apr 24
SC TO-C
Information about tender offer
19 Mar 24
6-K
Current report (foreign)
19 Mar 24
6-K
Bristol Myers Squibb Completes Acquisition of PureTech’s Founded Entity Karuna Therapeutics for $14 Billion
18 Mar 24
6-K
Current report (foreign)
4 Mar 24
6-K
Current report (foreign)
5 Feb 24
6-K
Current report (foreign)
4 Jan 24
6-K
PureTech Year End Update and Outlook for 2024
20 Dec 23
Latest ownership filings
SC 13G/A
Invesco Ltd.
12 Feb 24
4
GELESIS HOLDINGS, INC.
21 Sep 23
4
GELESIS HOLDINGS, INC.
14 Jun 23
4
GELESIS HOLDINGS, INC.
31 May 23
4
GELESIS HOLDINGS, INC.
3 May 23
SC 13G/A
Invesco Ltd.
10 Feb 23
SC 13D
Akili, Inc.
30 Aug 22
3
Akili, Inc.
29 Aug 22
SC 13G/A
Invesco Ltd.
11 Feb 22
3
GELESIS HOLDINGS, INC.
21 Jan 22
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Institutional ownership, Q3 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
News
PureTech Health FY 2023 GAAP EPS $(0.24) Beats $(0.93) Estimate, Sales $3.330M Down From $15.618M YoY
25 Apr 24
PureTech Launches Seaport Therapeutics With $100M Oversubscribed Series A; Daphne Zohar Steps Down To Lead Seaport; Bharatt Chowrira Appointed New CEO
9 Apr 24
PureTech Proposes $100M Capital Return Via a Tender Offer at 250 Pence/Share
19 Mar 24
PureTech Founded Entity Akili Announces Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx for Pediatric ADHD Patients in Japan
27 Feb 24
Press releases
PureTech Announces Annual Results for Year Ended December 31, 2023
25 Apr 24
PureTech Health: Notice of Results
18 Apr 24
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
16 Apr 24
PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers
11 Apr 24
PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions
9 Apr 24